| 000 | 01589 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518043921.0 | ||
| 264 | 0 | _c20200130 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1179-6901 | ||
| 024 | 7 |
_a10.1007/s40268-019-0277-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDong, Ruihua | |
| 245 | 0 | 0 |
_aPharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder. _h[electronic resource] |
| 260 |
_bDrugs in R&D _cSep 2019 |
||
| 300 |
_a255-265 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Sublingual |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aAsian People |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aBuprenorphine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNaloxone _xadministration & dosage |
| 650 | 0 | 4 |
_aOpioid-Related Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aTablets _xadministration & dosage |
| 700 | 1 | _aWang, Hongyun | |
| 700 | 1 | _aLi, Dandan | |
| 700 | 1 | _aLang, Liwei | |
| 700 | 1 | _aGray, Frank | |
| 700 | 1 | _aLiu, Yongzhen | |
| 700 | 1 | _aLaffont, Celine M | |
| 700 | 1 | _aYoung, Malcolm | |
| 700 | 1 | _aJiang, Ji | |
| 700 | 1 | _aLiu, Zeyuan | |
| 700 | 1 | _aLearned, Susan M | |
| 773 | 0 |
_tDrugs in R&D _gvol. 19 _gno. 3 _gp. 255-265 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40268-019-0277-9 _zAvailable from publisher's website |
| 999 |
_c29796860 _d29796860 |
||